Showing results (51-60 of 78) with videos related to
Sort By:
Pageof 8
Therapeutics and Clinical Risk Management|June 17, 2021
Italian Real-World Analysis of a Tyrosine Kinase Inhibitor Administration as First- or Second-Line of Therapy in Patients with Chronic Myeloid LeukemiaValentina Perrone, Elisa Giacomini, Margherita Andretta, et al.Italian Journal of Dermatology and Venereology|September 9, 2024
Healthcare resource utilization and related cost among hospitalized patients with prurigo nodularis: a retrospective cohort study using Italian health claims dataDonia Bahloul, Gianluca Ronci, Danielle L Isaman, et al.Fertility and Sterility|April 29, 2019
Seminal plasma of men with severe asthenozoospermia contain exosomes that affect spermatozoa motility and capacitationValentina Murdica, Elisa Giacomini, Alessandra Alteri, et al.European Journal of Medicinal Chemistry|June 27, 2015
Identification of N-acylhydrazone derivatives as novel lactate dehydrogenase A inhibitorsSebastiano Rupiani, Rosa Buonfiglio, Marcella Manerba, et al.Plos One|March 6, 2013
A natural-like synthetic small molecule impairs bcr-abl signaling cascades and induces megakaryocyte differentiation in erythroleukemia cellsSilvia Turroni, Manlio Tolomeo, Gianfranco Mamone, et al.Clinical Epidemiology|November 17, 2022
The Epidemiology, Treatment Patterns and Economic Burden of Different Phenotypes of Multiple Sclerosis in Italy: Relapsing-Remitting Multiple Sclerosis and Secondary Progressive Multiple SclerosisValentina Perrone, Chiara Veronesi, Elisa Giacomini, et al.Plos One|June 8, 2012
Palytoxin and an Ostreopsis toxin extract increase the levels of mRNAs encoding inflammation-related proteins in human macrophages via p38 MAPK and NF-κBRita Crinelli, Elisa Carloni, Elisa Giacomini, et al.Current Medical Research and Opinion|October 12, 2020
Treatment patterns, health resource consumption, and costs of patients with migraine in an Italian real-world settingValentina Perrone, Chiara Veronesi, Elisa Giacomini, et al.Advances in Therapy|December 23, 2022
The Economic Burden of Chronic Myeloid Leukemia in Patients with Later Lines: Findings from a Real-World Analysis in ItalyMassimo Breccia, Francesca Chiodi, Aurelio Pio Nardozza, et al.Journal of Clinical Medicine|July 9, 2022
Real-World Analysis of the Therapeutic Management and Disease Burden in Chronic Myeloid Leukemia Patients with Later Lines in ItalyMassimo Breccia, Francesca Chiodi, Aurelio Pio Nardozza, et al.Pageof 8